Pacific Center for Financial Services’s Microbot Medical MBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1
Closed -$2 476
2024
Q4
$2 Hold
1
﹤0.01% 487
2024
Q3
$1 Hold
1
﹤0.01% 485
2024
Q2
$2 Hold
1
﹤0.01% 478
2024
Q1
$2 Hold
1
﹤0.01% 468
2023
Q4
$2 Hold
1
﹤0.01% 390
2023
Q3
$2 Hold
1
﹤0.01% 417
2023
Q2
$3 Hold
1
﹤0.01% 406
2023
Q1
$3 Buy
+1
New +$3 ﹤0.01% 412
2022
Q3
$0 Hold
1
﹤0.01% 411
2022
Q2
$0 Hold
1
﹤0.01% 407
2022
Q1
$0 Hold
1
﹤0.01% 386
2021
Q4
$0 Hold
1
﹤0.01% 405
2021
Q3
$0 Hold
1
﹤0.01% 406
2021
Q2
$0 Buy
+1
New +$8 ﹤0.01% 350

Other funds holding MBOT

Pacific Center for Financial Services's MBOT Position: Q1 2025 in Review

Pacific Center for Financial Services sold out of Microbot Medical (MBOT) in Q1 2025, closing a stake of 1 share — an estimated $2 sold.

Pacific Center for Financial Services first reported a position in MBOT in Q2 2021 and held it in 14 quarters. The position peaked at $3 in Q2 2023. 43 funds tracked by Wall St. Rank hold MBOT as of Q1 2025.

  • Pacific Center for Financial Services reported no remaining Microbot Medical position as of Q1 2025 after selling out during the quarter.
  • Pacific Center for Financial Services sold 1 Microbot Medical share in Q1 2025, an estimated $2.
  • Pacific Center for Financial Services first reported a position in Microbot Medical in Q2 2021 and held it in 14 quarters.
  • Pacific Center for Financial Services's Microbot Medical position peaked at $3 in Q2 2023.
  • 43 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2025.

Based on Pacific Center for Financial Services's 13F filing for Q1 2025, filed 15 May 2025.